thiazoles has been researched along with Myelodysplastic Syndromes in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faiz, SA; Jimenez, CA; Sahay, S | 1 |
| Kim, S; Krysiak, K; Liu, T; Ndonwi, M; Shao, J; Shirai, CL; Walter, MJ | 1 |
| Birgens, H; Brown, Pde N; Dalseg, AM; Dufva, IH; Hasselbalch, HC; Jensen, MK; Vangsted, A | 1 |
| Bendit, I; de Alencar Fischer Chamone, D; de Mello Conchon, MR; Dias, L; Dorlhiac-Llacer, PE; Ferreira, P; Kumeda, C; Lima, W | 1 |
| Billström, R; Ekblom, M; Fioretos, T; Larsson, N; Lassen, C; Lilljebjörn, H; Richter, J | 1 |
| Feldman, EJ | 1 |
| Duong, VH; Jaglal, MV; Kale, V; Komrokji, RS; Lancet, JE; List, AF; Zhang, L | 1 |
2 review(s) available for thiazoles and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Pleural effusions in acute and chronic leukemia and myelodysplastic syndrome.
Topics: Acute Disease; Biopsy; Bone Marrow; Chronic Disease; Dasatinib; Humans; Leukemia; Myelodysplastic Syndromes; Pleura; Pleural Effusion; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2014 |
[Novel medical treatment modalities in hematology].
Topics: Aminoglycosides; Anemia, Hemolytic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Benzamides; Benzoates; Boronic Acids; Bortezomib; Carbazoles; Carrier Proteins; Cyclophosphamide; Dasatinib; Furans; Gemtuzumab; Hematologic Diseases; Humans; Hydrazines; Imatinib Mesylate; Immunologic Factors; Indoles; Lenalidomide; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Piperazines; Purpura, Thrombocytopenic; Pyrazines; Pyrazoles; Pyrimidines; Receptors, Fc; Recombinant Fusion Proteins; Rituximab; Thalidomide; Thiazoles; Thrombopoietin; Vidarabine | 2008 |
1 trial(s) available for thiazoles and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapy.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Dasatinib; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Pyrimidines; Risk; Salvage Therapy; Severity of Illness Index; Standard of Care; Thiazoles; Treatment Failure | 2013 |
4 other study(ies) available for thiazoles and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Biomarkers; Drug Resistance; Gene Expression; Gene Expression Regulation; Gene Knockdown Techniques; Hematopoietic Stem Cells; HSP70 Heat-Shock Proteins; Humans; Mitochondrial Proteins; Myelodysplastic Syndromes; Pyridines; RNA, Messenger; Thiazoles; Tumor Suppressor Protein p53 | 2017 |
Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors.
Topics: Benzamides; Chromosomes, Human, Pair 7; Clone Cells; Dasatinib; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Monosomy; Myelodysplastic Syndromes; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Young Adult | 2009 |
Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
Topics: Chromosomes, Human, Pair 7; Dasatinib; Female; Genes, ras; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Middle Aged; Monosomy; Mutation; Myelodysplastic Syndromes; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Prognosis; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyrimidines; ras Proteins; Thiazoles | 2010 |
Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants?
Topics: Adenine; Anthracyclines; Antineoplastic Agents; Biomarkers, Tumor; Cytarabine; Cytogenetics; Female; Germany; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Naphthalimides; Naphthyridines; Organophosphonates; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Thiazoles | 2011 |